Salivary cortisol release and hypothalamic pituitary adrenal axis feedback sensitivity in fibromyalgia is associated with depression but not with pain.
Results on hypothalamicpituitary-adrenal (HPA) axis function in fibromyalgia are heterogeneous and studies that integrate psychological and biological mechanisms in the search for pathways to fibromyalgia are rare. The goal of the study was to evaluate cortisol release and HPA axis feedback regulation in fibromyalgia and its association with psychopathology and pain. Beneath assessment of pain thresholds and self-report of pain, salivary free cortisol release over the day before and after intake of 0.5 mg of dexamethasone was measured in 21 female patients with fibromyalgia and 26 control women. Depression was assessed by questionnaires and clinical interview. We found reduced feedback sensitivity and slightly enhanced cortisol release in patients with fibromyalgia compared with healthy control subjects. Post hoc analyses showed that these effects are exclusively found in those patients, who also had major depressive disorder. Patients with fibromyalgia had lower pain pressure threshold, whereas heat pain thresholds were comparable with control subjects. Pain pressure and heat pain thresholds were not associated with cortisol release. On the other hand measurements of affective pain experience and depression were positively correlated with salivary cortisol over the day. Our results support the hypotheses that HPA axis related alterations are associated with affective disturbances, for example, depression, in patients with fibromyalgia.


CONCLUSIONS
The presented data suggest depression to be an important factor in HPA axis-related dysfunction in fibromyalgia. This might be one explanation for equivocal findings in the literature.
Wingenfeld
Katja
K
Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf & Schön Klinik Hamburg-Eilbek, Germany. k.wingenfeld@uke.uni-hamburg.de
Nutzinger
Detlev
D
Kauth
Joachim
J
Hellhammer
Dirk H
DH
Lautenbacher
Stefan
S
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D003866:Depressive Disorder / Q000209:etiology / Q000378:metabolism*; D003907:Dexamethasone / Q000494:pharmacology; D025461:Feedback, Physiological / Q000502:physiology; D005260:Female; D005356:Fibromyalgia / Q000150:complications / Q000378:metabolism* / Q000523:psychology*; D006358:Hot Temperature / Q000009:adverse effects; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism* / Q000503:physiopathology; D008875:Middle Aged; D010147:Pain Measurement / Q000379:methods*; D017288:Pain Threshold / Q000502:physiology / Q000523:psychology; D010913:Pituitary-Adrenal System / Q000378:metabolism* / Q000503:physiopathology; D011312:Pressure / Q000009:adverse effects; D012463:Saliva / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D003907:Dexamethasone; D006854:Hydrocortisone